Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details)

v3.23.3
Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details) - USD ($)
12 Months Ended
Sep. 19, 2022
Jun. 30, 2023
Jun. 30, 2022
Nov. 25, 2020
Subscription receivable   $ 204,000    
RubrYc Therapeutics, Inc. [Member]        
Sale of preferred stock $ 1,000,000      
Number of shares issued 102,354      
Sales Agreement | Cantor Fitzgerald [Member]        
Aggregate offering price       $ 100,000,000
Number of shares issued   5,782,871 175,973  
Proceeds from sale of shares, net of issuance cost   $ 6,400,000 $ 1,200,000  
Subscription receivable   $ 204,000